Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - NEW ENTERPRISE ASSOCIATES 13 LP
Last Updated 
8-Oct-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

NEW ENTERPRISE ASSOCIATES 13 LP: Declared Holdings
Company/RelationshipReportedShares  Ownership
Clovis Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGS:CLVS
(historical quotes, profile, other insiders)
3-Jun-132,279,781  Direct
DERMIRA, INC.
Beneficial Owner (10% or more)
NasdaqGS:DERM
(historical quotes, profile, other insiders)
8-Oct-143,502,922  Direct
Epizyme, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EPZM
(historical quotes, profile, other insiders)
14-Aug-14
15-Nov-13
4,743,240
   406,500
5,149,740
  Direct
  Indirect  
  Total
GlycoMimetics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:GLYC
(historical quotes, profile, other insiders)
15-Jan-144,093,377  Direct
Millennial Media, Inc. Common S
Beneficial Owner (10% or more)
NYSE:MM
(historical quotes, profile, other insiders)
29-Oct-128,196,614  Direct
Roka Bioscience, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ROKA
(historical quotes, profile, other insiders)
22-Jul-143,216,810  Direct
TESARO, Inc.
Beneficial Owner (10% or more)
NasdaqGS:TSRO
(historical quotes, profile, other insiders)
4-Jun-139,854,255  Direct
Workday, Inc. Common Stock
Beneficial Owner (10% or more)
NYSE:WDAY
(historical quotes, profile, other insiders)
9-Apr-130  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
8-Oct-14 69,112DERM Purchase at $16 per share.
(Cost of $1,105,792)
8-Oct-14 3,416,569DERM Acquisition (Non Open Market) at $0 per share.
2-Oct-14 17,241DERM Statement of Ownership
14-Aug-14 1,290,000EPZM Disposition (Non Open Market) at $0 per share.
22-Jul-14 383,333ROKA Purchase at $12 per share.
(Cost of $4,599,996)
22-Jul-14 2,828,743ROKA Acquisition (Non Open Market)
16-Jul-14 4,734ROKA Statement of Ownership
15-Jan-14 512,500GLYC Purchase at $8 per share.
(Cost of $4,100,000)
15-Jan-14 3,580,877GLYC Acquisition (Non Open Market)
15-Nov-13 *49,500EPZM Purchase at $19.31 - $20.31 per share.
(Cost of about $981,000)
14-Nov-13 *357,000EPZM Purchase at $19.04 - $20.91 per share.
(Cost of about $7,131,000)
5-Jun-13 5,633,240EPZM Acquisition (Non Open Market)
5-Jun-13 400,000EPZM Purchase at $15 per share.
(Cost of $6,000,000)
4-Jun-13 1,645,000TSRO Disposition (Non Open Market) at $0 per share.
3-Jun-13 1,139,890CLVS Disposition (Non Open Market) at $0 per share.
9-Apr-13 2,321,212WDAY Disposition (Non Open Market) at $0 per share.
9-Apr-13 2,321,212WDAY Acquisition (Non Open Market)
29-Oct-12 1,597,787MM Sale at $13.44 per share.
(Proceeds of $21,474,257)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?